Compounds > naltrexone

naltrexone and kelatorphan

naltrexone has been researched along with kelatorphan in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costentin, J; Dourmap, N; Michael-Titus, A1
Dickenson, AH; Stanfa, LC1
Crain, SM; Shen, KF2

Other Studies

4 other study(ies) available for naltrexone and kelatorphan

ArticleYear
Local enkephalins tonically modulate dopamine release in the striatum: a microdialysis study.
    Brain research, 1990, Jul-30, Volume: 524, Issue:1

    Topics: Amino Acid Sequence; Aminopeptidases; Analgesics; Animals; CD13 Antigens; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dipeptides; Dopamine; Enkephalins; Male; Molecular Sequence Data; Naltrexone; Neprilysin; Rats; Rats, Inbred Strains; Substrate Specificity

1990
Electrophysiological studies on the spinal roles of endogenous opioids in carrageenan inflammation.
    Pain, 1994, Volume: 56, Issue:2

    Topics: Analgesics; Animals; Carrageenan; Dipeptides; Dynorphins; Electrophysiology; Endorphins; Inflammation; Injections, Spinal; Male; Microelectrodes; Naltrexone; Nerve Fibers; Neurons; Nociceptors; Rats; Rats, Sprague-Dawley; Spinal Cord; Synaptic Transmission

1994
Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Brain research, 2007, Sep-05, Volume: 1167

    Topics: Analgesics, Opioid; Animals; Chronic Disease; Dipeptides; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; G(M1) Ganglioside; Hyperalgesia; Male; Mice; Morphine; Morphine Dependence; Naloxone; Naltrexone; Narcotic Antagonists; Nociceptors; Opioid Peptides; Receptors, Opioid, kappa; Substance Withdrawal Syndrome

2007
Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone.
    Brain research, 2008, Sep-22, Volume: 1231

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Analgesia; Analgesics; Animals; Cyclic AMP; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hyperalgesia; Male; Mice; Naltrexone; Narcotic Antagonists; Nociceptors; Phosphodiesterase Inhibitors; Receptors, G-Protein-Coupled; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Signal Transduction; Time Factors

2008